Inactive Instrument

Searle Co Ltd Share Price Pakistan S.E.

Equities

Pharmaceuticals

End-of-day quote Pakistan S.E.
- PKR - Intraday chart for Searle Co Ltd

Financials

Sales 2024 * 44.08B 158M 12.66B Sales 2025 * 50.94B 183M 14.63B Capitalization 20.94B 75.29M 6.01B
Net income 2024 * 1.22B 4.38M 350M Net income 2025 * 2.88B 10.37M 828M EV / Sales 2024 * 1 x
Net Debt 2024 * 22.97B 82.59M 6.6B Net Debt 2025 * 22.21B 79.85M 6.38B EV / Sales 2025 * 0.85 x
P/E ratio 2024 *
20.7 x
P/E ratio 2025 *
9.52 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 59.07%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer - 31/12/07
Director of Finance/CFO - 22/10/14
Chief Tech/Sci/R&D Officer - 31/12/15
Members of the board TitleAgeSince
Chief Executive Officer - 31/12/07
Director/Board Member 60 -
Director/Board Member - 25/02/21
More insiders
The Searle Company Limited is a Pakistan-based company, which is engaged in the manufacture of pharmaceuticals and other consumer products. The Company’s product categories include pharmaceutical, biopharmaceutical, nutraceutical, nutrition, consumer, and medical devices and disposables. The Company's product portfolio in the pharmaceutical range includes therapeutic areas, such as cardiovascular, respiratory care, gastroenterology, pain management, central nervous system (CNS), ortho care, neuropsychiatry, probiotics, antibiotics, and nutritional care. Its pharmaceutical products include Analgesic & Muscle-Relaxant, Anti-Allergy & Anti-Tussive, Anti-Anemic, Anti-Chelating, Anti-infective, Anti-Neoplastic, Anti-Thrombotic, Cardiovascular, Endocrinology & Metabolism. It also focuses on specialty generic branded portfolios and targeting differentiated products. Its subsidiaries include IBL HealthCare Limited, Searle Pharmaceuticals (Private) Limited, and others.
More about the company